| Primary |
| Product Used For Unknown Indication |
56.5% |
| Depression |
19.7% |
| Drug Use For Unknown Indication |
9.0% |
| Anxiety |
3.3% |
| Drug Use For Unknown Indication |
1.7% |
| Insomnia |
1.3% |
| Intentional Overdose |
1.3% |
| Major Depression |
0.8% |
| Musculoskeletal Pain |
0.8% |
| Antidepressant Therapy |
0.6% |
| Depressed Mood |
0.6% |
| Epilepsy |
0.6% |
| Panic Attack |
0.6% |
| Panic Disorder |
0.6% |
| Obsessive-compulsive Disorder |
0.4% |
| Anaemia |
0.4% |
| Angina Pectoris |
0.4% |
| Anxiety Disorder |
0.4% |
| Dyspepsia |
0.4% |
| Hallucination |
0.4% |
|
| Toxicity To Various Agents |
47.3% |
| Drug Abuse |
5.4% |
| Completed Suicide |
3.9% |
| Withdrawal Syndrome |
3.9% |
| Serotonin Syndrome |
3.1% |
| Sopor |
3.1% |
| Ventricular Tachycardia |
3.1% |
| Vomiting |
3.1% |
| Drug Exposure During Pregnancy |
2.3% |
| Intentional Drug Misuse |
2.3% |
| Respiratory Arrest |
2.3% |
| Rheumatoid Arthritis |
2.3% |
| Somnolence |
2.3% |
| Status Epilepticus |
2.3% |
| Suicidal Ideation |
2.3% |
| Suicide Attempt |
2.3% |
| Tremor |
2.3% |
| Vertigo |
2.3% |
| Weight Increased |
2.3% |
| Complex Regional Pain Syndrome |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
65.2% |
| Depression |
7.9% |
| Completed Suicide |
3.5% |
| Drug Use For Unknown Indication |
3.0% |
| Ill-defined Disorder |
3.0% |
| Major Depression |
2.4% |
| Sleep Disorder |
2.2% |
| Suicide |
2.2% |
| Bipolar Disorder |
1.9% |
| Drug Abuse |
1.6% |
| Generalised Anxiety Disorder |
1.1% |
| Restless Legs Syndrome |
1.1% |
| Drug Use For Unknown Indication |
0.8% |
| Deep Vein Thrombosis |
0.8% |
| Acute Myocardial Infarction |
0.5% |
| Anxiety |
0.5% |
| Chronic Hepatitis C |
0.5% |
| Contraception |
0.5% |
| Coronary Artery Disease |
0.5% |
| Dementia |
0.5% |
|
| Toxicity To Various Agents |
37.5% |
| Suicide Attempt |
13.8% |
| Overdose |
5.0% |
| Renal Impairment |
5.0% |
| Tremor |
3.8% |
| Unresponsive To Stimuli |
3.8% |
| Vomiting |
3.8% |
| Weight Loss Poor |
3.8% |
| Completed Suicide |
2.5% |
| Drug Exposure During Pregnancy |
2.5% |
| Hyponatraemia |
2.5% |
| Intentional Drug Misuse |
2.5% |
| Respiratory Arrest |
2.5% |
| Suicidal Ideation |
2.5% |
| Weight Increased |
2.5% |
| Abnormal Behaviour |
1.3% |
| Agitation |
1.3% |
| Bipolar Disorder |
1.3% |
| Blood Potassium Decreased |
1.3% |
| Cardiac Arrest |
1.3% |
|
| Concomitant |
| Hepatitis C |
13.4% |
| Product Used For Unknown Indication |
12.8% |
| Multiple Sclerosis |
10.2% |
| Plasma Cell Myeloma |
8.6% |
| Colon Cancer |
8.0% |
| Depression |
6.4% |
| Chronic Myeloid Leukaemia |
4.3% |
| Hypertension |
3.7% |
| Relapsing-remitting Multiple Sclerosis |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Breast Cancer |
3.2% |
| Non-small Cell Lung Cancer |
3.2% |
| Acromegaly |
2.7% |
| Anxiety |
2.7% |
| Tuberous Sclerosis |
2.7% |
| Agitation |
2.1% |
| Colorectal Cancer Metastatic |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Lower Respiratory Tract Infection |
2.1% |
| Myelodysplastic Syndrome |
2.1% |
|
| Vomiting |
10.7% |
| White Blood Cell Count Decreased |
9.5% |
| Paraesthesia |
7.1% |
| Oedema Peripheral |
6.0% |
| Urinary Tract Infection |
6.0% |
| Palpitations |
4.8% |
| Psychotic Disorder |
4.8% |
| Toxicity To Various Agents |
4.8% |
| Urticaria |
4.8% |
| Weight Decreased |
4.8% |
| Wheezing |
4.8% |
| Anaphylactic Reaction |
3.6% |
| Glossitis |
3.6% |
| Myalgia |
3.6% |
| Nausea |
3.6% |
| Neutropenia |
3.6% |
| Pancytopenia |
3.6% |
| Pulmonary Embolism |
3.6% |
| Sinusitis |
3.6% |
| Syncope |
3.6% |
|
